- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Trex Medical signs deal to buy XRE
Trex Medical continues to roll on the acquisition road. The holdingcompany for x-ray firms Lorad and Bennett X-Ray last week signeda letter of intent to buy XRE of Littleton, MA, a vendor of cardiaccath labs and angiography suites. XRE will give Trex
Trex Medical continues to roll on the acquisition road. The holdingcompany for x-ray firms Lorad and Bennett X-Ray last week signeda letter of intent to buy XRE of Littleton, MA, a vendor of cardiaccath labs and angiography suites.
XRE will give Trex Medical a presence in the upper end of x-rayto complement the positions Lorad and Bennett have in basic x-rayand mammography. When the deal is completed, XRE systems willbe sold through qualified Bennett and Lorad dealers, accordingto Trex Medical president and CEO Hal Kirshner. XRE also suppliescardiac cath labs to Philips on an OEM basis and had revenuesof $28.6 million last year.
Further synergies may come from the integration of Trex Medical'shigh-end digital detector technology that is under development.For example, a flat-panel digital detector could be substitutedfor the image intensifier on an XRE cardiac cath lab, accordingto Kirshner.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
